126 related articles for article (PubMed ID: 3922501)
1. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.
Shattock AG; Irwin FM; Morgan BM; Hillary IB; Kelly MG; Fielding JF; Kelly DA; Weir DG
Br Med J (Clin Res Ed); 1985 May; 290(6479):1377-80. PubMed ID: 3922501
[TBL] [Abstract][Full Text] [Related]
2. The serology of delta hepatitis and the detection of IgM anti-HD by EIA using serum derived delta antigen.
Shattock AG; Morris M; Kinane K; Fagan C
J Virol Methods; 1989 Mar; 23(3):233-40. PubMed ID: 2654168
[TBL] [Abstract][Full Text] [Related]
3. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology of hepatitis A, B, and D viruses and human T-lymphocyte tropic viruses in Japanese drug abusers.
Kiyosawa K; Oofusa H; Saitoh H; Sodeyama T; Tanaka E; Furuta S; Itoh S; Ogata H; Kobuchi H; Kameko M
J Med Virol; 1989 Nov; 29(3):160-3. PubMed ID: 2559157
[TBL] [Abstract][Full Text] [Related]
6. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
Lyra LG
Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
[TBL] [Abstract][Full Text] [Related]
7. [Delta virus superinfection in a patient with chronic viral hepatitis B].
Decker T; Baumgarten R; Roschlau G
Zentralbl Allg Pathol; 1986; 132(4):283-8. PubMed ID: 3541449
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
[TBL] [Abstract][Full Text] [Related]
9. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
Hansson BG; Moestrup T; Widell A; Nordenfelt E
J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease.
Novick DM; Farci P; Karayiannis P; Gelb AM; Stenger RJ; Kreek MJ; Thomas HC
J Med Virol; 1985 Apr; 15(4):351-6. PubMed ID: 3884737
[TBL] [Abstract][Full Text] [Related]
11. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
12. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
13. Fulminant B viral hepatitis: role of delta agent.
Govindarajan S; Chin KP; Redeker AG; Peters RL
Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
Ponzetto A; Seeff LB; Buskell-Bales Z; Ishak KG; Hoofnagle JH; Zimmerman HJ; Purcell RH; Gerin JL
Hepatology; 1984; 4(6):1111-5. PubMed ID: 6500507
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of delta infection.
Moestrup T; Hansson BG; Widell A; Nordenfelt E
Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
[TBL] [Abstract][Full Text] [Related]
16. Infection with the delta agent in chronic HBsAg carriers.
Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
[TBL] [Abstract][Full Text] [Related]
17. Chronic evolution of acute hepatitis type B: prevalence and predictive markers.
Bortolotti F; Bertaggia A; Crivellaro C; Armigliato M; Alberti A; Pontisso P; Chemello C; Realdi G
Infection; 1986; 14(2):64-7. PubMed ID: 3710594
[TBL] [Abstract][Full Text] [Related]
18. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.
Lavarini C; Farci P; Chiaberge E; Veglio V; Giacobbi D; Bedarida G; Susani G; Toti M; Almi P; Caporaso N
Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1254-6. PubMed ID: 6416354
[TBL] [Abstract][Full Text] [Related]
19. Fulminant delta hepatitis in chronic hepatitis B infection.
De Cock KM; Govindarajan S; Redeker AG
JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic usefulness of anti-HBc-IgM and anti-HD antibodies in acute viral hepatitis.
Esteban R; Buti M; Jardi R; Hernandez JM; Bacardi R
Gastroenterol Clin Biol; 1986 Nov; 10(11):748-51. PubMed ID: 3803810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
